Event
High Content Imaging and Flow Cytometry in Drug Discovery 2025

📅 Date: November 19-20, 2025
📍 Location: Stevenage, UK
Advancing Phenotypic Discovery Together
This conference gathers innovators in high-content imaging and flow cytometry. It helps the field move faster and smarter in early-stage research.
Axxam will be at Booth #06.
Our delegates:
Katie Headland — Senior Director, Business Development UK
Fernanda Ricci — Head, Advanced Cellular Assays
They are happy to meet and discuss your project needs.
Axxam Scientific Talk
Shaping the Future of Early Drug Discovery Through Omics and Advanced Biological Models
🗓 Day 1
⏱ 3:50 PM – 4:20 PM
👩🔬 Speaker: Fernanda Ricci
This talk highlights:
How multi-omics strategies identify stronger targets
Why advanced biological models improve predictability
How imaging and flow cytometry translate complex cellular behavior into clear decisions
This session shows a practical path from insights to hits.
High-Content and High-Impact Data
We deliver deep cellular knowledge that supports confident decisions. Our high-content imaging platform captures disease-relevant processes within physiologically complex cell models, including neurobiology, immunology, metabolism and rare diseases.
We apply multiplexed, automated assays to monitor critical functions such as autophagy, DNA damage, mitochondrial changes, cell-cycle alterations and pathological aggregates.
Our screening formats use both standard cell lines and advanced systems like primary cells or iPSC-derived models. These enable meaningful mechanistic insights and better translational value.
Available off-the-shelf or fully customised, our high-content assays help you prioritise hits, validate mechanisms, and transition into lead optimisation with speed and confidence.
Meet us in UK
Are you attending?
We would be pleased to connect and explore opportunities.
📩 Book a meeting with Katie or Fernanda
CONTACT US or write us to request@axxam.com


